Chandan Healthcare Share Price Today | Stock Price & Chandan Healthcare Share Screener
Track the current Chandan Healthcare share price and stock price live with TickJournal's free stock screener. Check Chandan Healthcare yearly highs lows for the annual price range and momentum. Use the Chandan Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Chandan Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹77 and net income of ₹5, with EBITDA of ₹13, an operating margin of 15.0% and a profit margin of 6.5%.
Chandan Healthcare Share Price Chart
Track the current stock price of Chandan Healthcare with an interactive chart. Analyse CHANDAN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Chandan Healthcare stock quote in one place.
Chandan Healthcare Company Profile - Fundamental Screener
Screen Chandan Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CHANDAN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE0B2N01016.
Company Details
Classification
Identifiers and Leadership
Chandan Healthcare Balance Sheet Screener
Screen CHANDAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹290, up from ₹211 in 2025.
Latest statistics put total assets at ₹290 and shareholder funds at ₹176, with a leverage ratio of 0.35.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
Assets |
||||||
| Total Assets | 290 | 211 | 118 | 98 | 82 | 65 |
| Current Assets | 165 | 111 | 61 | 54 | 43 | 37 |
| Fixed Assets | 101 | 76 | 49 | 33 | 29 | 20 |
Liabilities |
||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 36 | 28 | 17 | 12 | 10 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||
| Total Equity | 176 | 126 | 44 | 30 | 27 | 24 |
| Share Capital | 25 | 25 | 20 | 20 | 20 | 20 |
| Reserves & Surplus | 145 | 98 | 21 | 7 | 4 | 4 |
Chandan Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Chandan Healthcare income statement and profit fundamentals. Analyze CHANDAN quarterly results. Chandan Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹77 and net profit was ₹5, equal to earnings per unit of ₹2.01, at an operating margin of 15%.
In that period expenses were ₹64, interest cost ₹2 and tax ₹3. The next period listed, 2026-Jun, shows revenue of ₹82 and net profit of ₹8.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Dec |
|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||
| Revenue | 77 | 82 | 65 | 69 | 69 | 66 | 55 |
| Expenses | 64 | 61 | 52 | 54 | 54 | 55 | 46 |
Operating Costs and Margins | |||||||
| EBITDA | 13 | 21 | 13 | 15 | 15 | 10 | 9 |
| Operating Profit % | 15.00% | 24.00% | 16.00% | 20.00% | 21.00% | 15.00% | 16.00% |
| Depreciation | 4 | 5 | 3 | 4 | 3 | 2 | 1 |
| Interest | 2 | 5 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | |||||||
| Profit Before Tax | 8 | 12 | 9 | 10 | 11 | 7 | 7 |
| Tax | 3 | 4 | 3 | 3 | 3 | 2 | 2 |
| Net Profit | 5 | 8 | 6 | 6 | 8 | 5 | 4 |
| EPS | 2.01 | 3.07 | 2.64 | 2.37 | 3.19 | 1.86 | 2.10 |
Chandan Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen CHANDAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹16, and net cash flow was an outflow of ₹3.
Over the same period, investing activities used ₹40 and financing activities provided ₹21.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
Cash from Operations and Investing | |||||
| Operating Activities | 16 | -3 | 1 | 5 | 6 |
| Investing Activities | -40 | -62 | -15 | -7 | -11 |
Financing and Net Cash | |||||
| Financing Activities | 21 | 67 | 16 | 3 | 4 |
| Net Cash Flow | -3 | 2 | 2 | 1 | -1 |
Chandan Healthcare Shareholding Pattern Screener
See Chandan Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Chandan Healthcare promoter holding and ownership changes for CHANDAN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 49.55%, foreign institutions 0.01%, domestic institutions 5.03% and the public 39.50%, spread across 1,624 shareholders.
The shareholder count was 1,624 in 2026-Mar, compared with 1,591 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Feb | 2025-Mar | 2025-Sept | 2025-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|
Promoter Holding | |||||||
| Promoter Holding | 49.55% | 49.61% | 49.20% | 49.43% | 49.47% | 49.47% | 69.93% |
Institutional Investors | |||||||
| FII Holding | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 5.03% | 5.09% | 0.00% | 0.00% | 0.00% | 4.76% | 0.00% |
Government, Public and Others | |||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 39.50% | 39.10% | 32.39% | 33.00% | 37.07% | 39.93% | 0.00% |
| Other Holding | 5.92% | 6.19% | 18.41% | 17.56% | 13.46% | 5.84% | 30.07% |
| Shareholder Count | 1,624 | 1,591 | 59 | 897 | 1,307 | 1,464 | 59 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Chandan Healthcare. Chandan Healthcare dividend yield can be compared with peers and other stocks in the market.
Chandan Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Chandan Healthcare stock. Check CHANDAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Chandan Healthcare Market Events Screener - Corporate Actions
Get Chandan Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Chandan Healthcare stock events that may affect CHANDAN share price, along with derivatives, futures and options activity and sector gainers.
7 corporate actions are listed, the most recent entry being Extraordinary General Meeting dated August 29, 2026, with a record date of August 29, 2026.
It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 29, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-29 | 2026-08-29 | Extraordinary General Meeting | NA | -9.49% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 1.41% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -0.02% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 4.65% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -6.38% |
| 2025-11-06 | 2025-11-06 | Extraordinary General Meeting | NA | 10.09% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | 4.86% |
Chandan Healthcare Competitors Screener - Peer Stocks Comparison
Screen CHANDAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 33,352 | 60.10 | 2,864 | 12.11% | 510 | 64.65 |
| Vijaya Diagnostic Centre | 14,808 | 81.17 | 835 | 19.34% | 173 | 42.34 |
| Metropolis Healthcare | 11,234 | 57.53 | 1,671 | 24.15% | 191 | 33.31 |
| Thyrocare Technologies | 8,502 | 49.47 | 846 | 20.48% | 163 | 36.26 |
| Nephrocare Health Services | 6,634 | 78.39 | 1,023 | 32.93% | 77 | 34.74 |
| Suraksha Diagnostic | 1,851 | 52.79 | 314 | 22.55% | 31 | 65.93 |
| Krsnaa Diagnostics | 1,816 | 18.47 | 816 | 9.90% | 101 | 53.67 |
| 3B BlackBio DX | 1,468 | 24.79 | 142 | 27.17% | 61 | 72.60 |
| One Global Service Provider | 1,032 | 14.13 | 499 | 237.48% | 70 | 43.80 |
| Health X Platform | 907 | -34.91 | 1,378 | 17.65% | -1 | 37.93 |
Chandan Healthcare Company Announcements - News & Reports Screener
Screen CHANDAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 23.07 and the P/B ratio is 3.42, with earnings per unit of ₹11.07. Market capitalisation stands at ₹568.51 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 5, 2026. This page covers 6 balance sheet periods, 7 income statement periods, 5 cash flow years and 7 shareholding periods. Information is provided for research and is not investment advice.